The skin is a complex immunological niche providing immunity to invading pathogens while simultaneously maintaining tolerance to innocuous environmental antigens. Consistent with this complex response, the skin is resident to both immunosuppressive and effector cell populations whose activities are tightly regulated. While NKT cells can activate immune responses in the skin, this review will highlight studies on UV-induced photodamage, models of NMSCs, transplantation and allergic inflammation where NKT cells appear to have an immunosuppressive role in the skin. J. Leukoc. Biol. 
Introduction
NKT cells are a subset of innate-like T cells that express an ␣␤ T cell receptor recognizing glycolipids bound to the MHC-I like molecule, CD1d [1] . CD1d is broadly expressed on lymphoid and myeloid cells, as well as dermal dendritic cells and keratinocytes but interestingly, at constitutively low levels on LCs in the skin [2] [3] [4] . Two CD1d-restricted NKT subsets, types I and II, are generally recognized based on the expression (or not) of the TCR V␣14J␣18 (V␣24J␣18 in humans) gene segment in mice [5] . Unlike conventional T cells that express a diverse array of ␣ and ␤ TCRs, type I NKT cells express a semiinvariant TCR-␣ protein paired with a limited repertoire of TCR-␤ chains (most commonly, V␤8,7,2 in mice and V␤11 in humans) [6] . In mice, as a proportion of total T lymphocytes, NKT cells are most frequent in the liver (30 -50%), bone marrow (20 -30%), and thymus (10 -20%) . Their frequency in other tissues is considerably less, including spleen (3%), lymph node (0.3%), and blood (4%) [7] . In humans, most studies have been limited to peripheral blood, where NKT cell numbers are variable and represent 0.1-0.5% of leukocytes [8] .
Interestingly, NKT cells are present in human liver (ϳ4% of hepatic T cells), although at much lower frequency than those found in mouse liver [9] . The frequency of NKT cells in skin is not well-reported; however, in allergic contact dermatitis, human skin NKT cells varied from 1.72% to 33% of the cellular infiltrate [10] . Reports in mouse skin indicate that NKT cells represent ϳ0.03% of cells in healthy skin and ϳ0.6% of cells in hyperplastic skin [11] .
Potential ligands for type I NKT cells include GSLs and phospholipids with ␣-anomeric sugars attached to a lipid chain that are derived from bacterial, plant, protozoan, and mammalian species [12] . Type I NKT cells are defined frequently by their strong affinity to ␣-GalCer, a compound derived from marine sponges, bound to CD1d. When stimulated with ␣-GalCer or synthetic analogs of this compound, these cells rapidly produce an array of pro-and anti-inflammatory cytokines (e.g., IFN-␥, TNF-␣, IL-17, IL-4, IL-10, and IL-13), which contribute to controlling infection and preventing autoimmunity and anti-tumor immunity. Whereas ␣-GalCer is a potent, marine-derived NKT ligand, several mammalian and microbial ligands have been suggested to stimulate NKT cells [5] , including GSLs, such as mammalian isoglobotrihexosylceramide [13] and microbial ␣-glucuronsylceramide [14] , and mammalian phospholipids, such as phosphatidylinositol and phosphatidylcholine [15, 16] . More recently, it has been suggested that endogenous, ␤-structured GSLs, such as ␤-GlcCer, may be the potential endogenous ligands for NKT cells, given the lack of ␣-structured GSLs in mammals [17] . Interestingly, type I NKT cells can support and suppress immune responses depending on the immune context and in some cases, involving different subsets characterized by expression of the CD4 and NK1.1 molecules [18, 19] . NKT cells have been targeted successfully to amplify anti-tumor T cell responses and provide tumor rejection by vaccination with the NKT-stimulating adjuvant ␣-GalCer [20 -23] . Alternatively, stimulation of type 1 NKT cells with ␣-GalCer can suppress allergic asthma symptoms in a mouse model [24] .
Type II NKT cells are also CD1d-restricted, but unlike type I cells, they express an array of different ␣ and ␤ chains and have low-affinity for ␣-GalCer. Instead, type II NKT cells re-spond to a wide array of lipid and nonlipid antigens and are better suited to bind ␤-linked self-glycolipids, such as sulfatide, rather than microbe-associated ␣-linked glycolipid antigens [25] . Sulfatide is a sulfated form of ␤-GalCer, which is enriched in neuronal tissue [26] . Type II NKT cells are recognized for their suppressive effect on tumor immunity [27] [28] [29] . Recently, a population of NKT cells, which recognize ␣-GalCer and ␣-GlcCer but express a TCR V␣10J␣50 complex, has been demonstrated in mice, indicating that NKT cells do not always fall into two distinct categories [30] .
Whereas subsets of NKT cells have been identified clearly and can play different roles within the immune system, the tissue context of any single NKT subset can also be important in determining cell function [31] . NKT cells can have immunosuppressive and immunostimulatory roles in the skin. In psoriasis, a chronic inflammatory skin disease, increased numbers of human TCR V␣24 ϩ cells were observed in psoriatic lesions relative to control skin and positively correlated with the severity of disease [32] [33] [34] [35] . In addition, there is overexpression of CD1d on keratinocytes within human psoriatic plaques, and these cells are capable of activating human NKT cell lines in vitro to secrete IFN-␥ [3] . A pathogenic role for NKT cells is also supported by mouse studies showing that injection of a human NKT cell line (derived from a psoriatic patient) into SCID mice bearing prepsoriatic human skin resulted in a psoriatic plaque [36] . Whereas an immunostimulatory role for NKT cells in psoriasis is evident, the remainder of this review will focus on immunosuppression mediated by NKT cells in a variety of skin pathologies, particularly UV-induced immunosuppression (summarized in Fig. 1 ).
NKT CELLS, UV RADIATION, AND SKIN CANCER
Skin cancers consist of melanomas and NMSCs, with the latter deriving from transformation of epithelial cells. NMSCs are the most commonly diagnosed cancers worldwide, consisting of basal and squamous cell carcinomas [42] . Sunlight-derived UV radiation is the primary trigger for NMSCs [43, 44] , inducing both mutated forms of P53 [45, 46] and Ras [47] to drive tumor initiation and activating AP-1 and cyclooxygenase 2 expression for tumor promotion, in addition to generating systemic suppression of the immune response [48 -51] . Several mechanisms contribute to UV-induced immunosuppression and the outgrowth of skin tumors, including a suggested role for NKT cells [37] .
Early studies on immunosuppression in UV-derived skin cancers demonstrated that transplanted tumors from UV-irradiated mice were rejected from untreated, syngeneic recipients, implying that the anti-tumor immune response in donor UVtreated mice had become tolerized or suppressed [52] . Follow-up studies by this group showed that "suppressor lymphocytes" induced after UV treatment were responsible for facilitating tumor development [49] . Characterization of the suppressor lymphocyte population(s) in later years revealed a role for NKT cells and T regs , as well as regulatory B cells [37, [53] [54] [55] .
Mice treated with UV radiation have a suppressed DTH response relative to the DTH response observed in UV-treated, CD1d
Ϫ/Ϫ animals [37] . Furthermore, suppression could be transferred, as purified CD4 ϩ DX5 ϩ cells, derived from UVirradiated mice, were able to suppress a DTH response in wildtype mice but not CD1d Ϫ/Ϫ mice. As a control, CD4 ϩ DX5 ϩ cells from nonirradiated mice were unable to suppress the DTH response in wild-type or CD1d Ϫ/Ϫ recipients. This suggests that a CD1d-restricted, CD4 ϩ DX5 ϩ cell population, presumably a NKT cell, was responsible for suppression of DTH in this model system. In the same study, transferred CD4 ϩ DX5 ϩ T cells ("NKT cells") from UV-exposed animals permitted outgrowth of normally regressive UV-induced tumors [37] . Perhaps surprisingly, given the earlier, nonspecific suppression 
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Increase in IDO in myeloid cells [11, 39] Skin graft acceptance [40] Suppression of contract hypersensitivity [41] Outcome Stimulation Figure 1 . Proposed mechanisms of NKT-mediated immunosuppression in the skin. Several stimuli, including UV light, oncogene-driven hyperplasia, contact sensitizers, and mismatched skin grafts, interact with NKT cells to induce cytokines that produce a range of immunosuppressive outcomes in the skin.
of DTH responses, transfer of the DX5 ϩ population from UVexposed donor animals did not have an effect on the growth of chemically induced tumors in the recipients. The involvement of CD1d was not explored in the tumor experiments. This is important because DX5 ϩ T cells are not exclusively NKT cells and may include conventional antigen-specific T cells with suppressive ability [56] . Why the suppressor cells should be nonspecific in the DTH response but tumor-specific in the latter experiments is unexplained. It might suggest that two different suppressor cells are active within the DX5 ϩ population, one that suppresses DTH via CD1d interactions and a second population that suppresses UV-induced tumors in a tumor-specific manner. Alternatively, the same CD1d-restricted, suppressive population may need interaction with a recruited cell population common to UV tumors and DTH but lacking in chemically induced tumors. Further transfer experiments, using J␣18
Ϫ/Ϫ mice exposed to UV radiation and avoiding the use of the DX5 marker, might help to resolve the role of type 1 NKT cells in this system.
One complication of using CD1d Ϫ/Ϫ mice in UV studies of the skin is the direct role this molecule can have in tumor formation and skin inflammation. Keratinocytes from mice lacking CD1d are more susceptible to UV-induced apoptosis and carried fewer p53 mutations, and subsequently, the mice developed fewer skin cancers than CD1d-sufficient controls [57] . A second study also showed that CD1d Ϫ/Ϫ mice, but not J␣18 Ϫ/Ϫ or TCR-␣ Ϫ/Ϫ mice, resist UVB-induced skin inflammation associated with sunburn [58] . These data reveal an unexpected, direct role for CD1d, independent of NKT cells, in the control of skin disease.
The endogenous ligand(s) induced by UV radiation and bound to CD1d for activation of NKT cells are unknown. Skin contains high levels of ␤-GlcCer that are processed to ceramides by the enzyme ␤-glucocerebrosidase. This enzymatic activity is lost in the presence of UVB radiation, allowing for an accumulation of ␤-GlcCer in the epidermis [59] . In a model of chronic GVHD, ␤-GlcCer was able to increase IL-4 and decrease IFN-␥, reducing pathology scores in the skin, liver, and bowel [60] . Synthetic mimics of ␤-GlcCer were able to activate human and mouse NKT cells to produce IFN-␥ and IL-4 [61] . One study showed that ␤-GlcCer Ϫ/Ϫ cells expressing CD1d were unable to activate mouse V␣14J␣18 NKT cell hybridomas [62] . However, in the same study, ␤-GlcCer added directly to CD1d molecules in a cell-free presentation assay failed to activate the NKT cell hybridomas, despite binding efficiently to CD1d. This suggests that intact ␤-GlcCer bound to CD1d is not the ligand that activates NKT cells directly but instead, might be a precursor that requires further cellular processing or an accessory protein that facilitates the binding of the natural ligand to CD1d. Consequently, we speculate that ␤-GlcCer may represent an important UV-regulated glycolipid that activates skin NKT cells indirectly, thus providing a potential link between UV radiation and the suppressive effects of NKT cells in the skin that warrants further investigation.
We might also speculate that UV radiation could alter microbial glycolipid presentation in the skin by CD1d through changes to the array of commensal skin microbes. Indeed, exposure to UV radiation does kill human skin resident microbes, although it is unknown if this alters the range of glycolipids presented by CD1d [63] . Recent studies in mice have shown that commensal bacteria in the gut can influence the numbers of iNKT cells [64] , although it remains to be seen if skin commensals can impact on NKT cells.
Exposure to UVB light also promotes the conversion of cutaneous vitamin D to the biologically active metabolite vitamin D 3 [65] , which has been shown to be immunomodulatory [66] . Interestingly, VDR is expressed on iNKT cells and has been shown to be important for the thymic development of iNKT cells [67] , while being dispensable for conventional T cell development [68] . In this same study, purified iNKT cells from VDR knockout mice produced less IFN-␥ and IL-4 than their wild-type counterparts in response to ␣-GalCer. Consequently, signaling through the VDR can impact on NKT cell function, and it will be interesting to determine if this occurs in mature skin NKT cells to generate a suppressive population. Alternatively, vitamin D 3 signaling in the skin could act on APCs and thus, indirectly impact on the generation of suppressive NKT cells. Exposure to vitamin D 3 or the synthetic analog calcipotriol reduces the number of LCs in human and mouse skin and diminished antigen presentation to conventional T cells in vitro [69 -71] . A link between LC and NKT suppression after vitamin D 3 treatment has not been demonstrated, but LC from UV-treated mice are controversially involved in immunosuppression. LCs from UV-irradiated mice were able to transfer suppression of a CHS response to topically applied DNFB in immunocompetent mice but not mice deficient in NKT cells [38] . The development of immune suppression strongly correlated with the presence of migrated LCs in the lymph nodes and the production of IL-4 from NKT cells. However, a second study in mice suggested that LCs were dispensable for UV-mediated immunosuppression, although the involvement of NKT cells was not examined [72] . It was suggested that differences in UV dosimetry might account for the different outcomes in these two studies. Further investigation into the links among UV-, vitamin D 3 -, LC-, and NKT-immunosuppressive function within the skin would seem warranted.
NKT CELL IMMUNOSUPPRESSION DURING ONCOGENE-DRIVEN SKIN HYPERPLASIA
NKT-mediated suppression of immune responses to skin cancers has also been studied in mice expressing oncogenes. Our group has used K14E7 transgenic mice, in which the HPVE7 protein is expressed in the epidermis under the control of a keratin 14 promoter to demonstrate a suppressive role for type I NKT cells [11] . Skin grafts from K14E7 mice fail to be rejected when transplanted onto syngeneic, nontransgenic recipients, despite the presence of the HPVE7 protein as a foreign viral protein. Interestingly, when donor K14E7 grafts, lacking or containing NKT cells, were placed side-by-side on the same immunocompetentrecipient mouse, only NKT Ϫ/Ϫ grafts were rejected, suggesting that these cells suppress the immune response locally in the skin. Furthermore, it was NKT cell production and regulation of IFN-␥ in the skin that contributed to suppression, most likely through an affect of IDO produced by IFN-␥-responsive myeloid cells [11, 39] . Further studies in this model also showed a broader suppressive role for NKT cells, as NKT Ϫ/Ϫ recipient mice also rejected K14E7 grafts, alluding to additional systemic effects of NKT cells by impairing the generation and activity of antigen-specific T cells [73] . This systemic immunosuppression occurred independently of FoxP3 ϩ T regs and IFN-␥, IL-10, or IL-17 production but involved the reduction in capacity of lymph node resident APCs to cross-present antigen to CD8 T cell precursors. Strangely, we have also shown that NKT cells are capable of promoting CD8 T cell effector function and skin graft rejection when other epithelial antigens (such as ovalbumin) are transgenically expressed in the skin [74] . This discrepancy may lie within the attraction of IFN-␥-responsive, suppressive myeloid cells to the hyperplastic, precancerous skin of K14E7 transgenic mice.
IMMUNOSUPPRESSION BY NKT CELLS DURING SKIN TRANSPLANTATION
The rejection of organ transplants from mismatched individuals is largely dictated by the immune response. As a consequence, conditioning regimes that suppress the immune system before transplantation are frequently used to promote transplant acceptance. In one murine study, pretreatment of recipients with injection of donor spleen cells, along with the immunosuppressive agent cyclophosphamide, resulted in the acceptance of donor skin grafts containing multiple minor antigen mismatches. However, this same pretreatment in NKT Ϫ/Ϫ recipient mice resulted in skin graft rejection, suggesting a systemic role for NKT cells in tolerance induction [75] . Further studies indicated that the suppressive action did not appear to be mediated by NKT production of IL-4, IL-10, or IFN-␥ [76, 77] , and therefore, the mechanism remains elusive. In a different transplant setting, allogeneic bone marrow transplants are often used in the treatment of blood cancers but have the unwanted side-effect of inducing GVHD, including skin pathology. Several murine studies indicate that NKT cells are capable of suppressing GVHD, generally through the production of IL-4 [78, 79] .
Whereas strong rejection reactions are seen in multiple minor antigen-mismatched skin grafts, the immune response can also recognize single antigen mismatches in the skin. One such mismatch is the male antigen, H-Y, introduced into the female system. H-Y-mismatched skin-graft survival is decreased in NKT deficient mice [40] . Survival of these grafts could be improved by adoptive transfer of NKT cells back into the hosts and further improved again by preactivating these transferred NKT cells with ␣-GalCer. The suppression appeared to be mediated by IL-10 in this model and occurred locally in the skin. Furthermore, the role of NKT cells as suppressors in the skin appears to favor minor antigen mismatches, as NKT cells were unable to control immunity against fully MHC-mismatched skin grafts in the same experiments. Understanding how the "strength" of an immune reaction relates to the suppressive contribution of NKT cells remains a mystery. One possibility is that the small number of suppressive NKT cells in the skin becomes overwhelmed by a high frequency of antigen-reactive CD8 T cells. Certainly, our group has found that NKT-mediated immune suppression in HPVE7-expressing skin grafts can be overcome by increasing the numbers of effector CD8 T cells [80] .
NKT CELLS IN HYPERSENSITIVITY RESPONSES IN THE SKIN
Hypersensitivity responses to chemicals, such as DNFB, applied to the skin are largely a T cell-mediated pathology involving initiation and effector phases. NKT cells have been shown to suppress the murine immune response to DNFB within the skin through the production of IL-4 and IL-13 and independently of FoxP3 T regs [41] . NKT cells were activated to produce IL-4 and IL-13 in response to CD1d-presented haptens to suppress CHS. In contrast, other studies suggest that NKT cells exacerbate hypersensitivity responses [81, 82] and have shown that murine NKT cells accumulate in the skin following sensitization to nickel [83] , whereas large numbers of NKT cells can also infiltrate human skin during contact dermatitis [10, 84] . In accordance with enrichment of NKT cells in the skin, studies of the peripheral blood in human atopic dermatitis demonstrate a reduction in NKT cells [85] . In murine studies, where NKT cells initiate CHS, the process likely involves IL-4 production by NKT cells, leading to B-1 cell activation, IgM production, and the initiation of complement cascades to attract lymphocytes to the skin [86] . It is therefore possible that NKT cells play different roles in the initiation (within lymph organs) and effector phases (in the skin) of the CHS response, although this has not been demonstrated clearly. Differences in the protocols/chemicals used to elicit CHS or the genetic background of the mice may also help explain the suppressive or promoting effects of NKT cells in each situation.
CONCLUDING REMARKS
Immunosuppression mediated by NKT cells in the skin has, so far, been demonstrated in settings of exposure to UV light, epithelial hyperplasia, minor transplantation antigens, and contact sensitizers. The link between these stimuli and the ligands bound to CD1d in the skin that induce NKT cells is still unknown, with the ␤-GlcCer family, vitamin D 3 , and skin microbes potentially involved. Most documented suppression in the skin by NKT cells is a consequence of IL-4 and IL-10, which can directly or indirectly down-regulate lymphocyte activity. However, in a cancerous setting, the infiltration of myeloid-derived suppressor cells provides an IFN-␥-responsive population that can also suppress immune responses. Given that type I NKT cells can be a major source of IFN-␥, it is likely that skin NKT cells contribute to regulation of tumor immunity in this setting. Whereas NKT-suppressive function is well-documented, the subsets of NKT cells in the skin mediating suppression remain poorly characterized. Designing immunotherapies to circumvent NKT immunosuppression will require greater knowledge of these subsets, their ligands, and the inflammatory context presented to NKT within the skin. 
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